In 2004 the European Organisation of Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (now Cutaneous Lymphoma Tumour Group) organised a workshop to initiate the development and publication of a European consensus on the treatment of mycosis fungoides (MF) and Sézary Syndrome (SS). This effort resulted in the publication of the first EORTC-consensus recommendations for the treatment of MF/SS in 2006 which were revised and updated in 2017. 1
The EORTC-Cutaneous Lymphoma Tumour Group meets annually to shed light on the latest developments in the cutaneous lymphoma field in the areas of diagnosis, research and treatment. The Annual Meeting welcomes not only Dermatologists focusing on skin cancer, but also Pathologists, Hematologists, Oncologists, Image Diagnostics Specialists and Radiologists. Young scientists and researchers in the field are encouraged to participate, bringing into the field a fresh aura and paving the road for the next generation of experts.2
1 EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023. Latzka, Johanna et al. European Journal of Cancer, Volume 195, 113343. https://www.ejcancer.com/article/S0959-8049(23)00645-7/fulltext
2 EORTC-CLTG Annual Meeting 2025. Welcome Letter. https://www.eortc-cltg2025.org/
The Cutaneous Lymphoma Foundation has maintained a long relationship with the Cutaneous Lymphoma Tumours Group. The relationship strengthens the Foundation's network in order to help connect patients from outside the United States with local experts. Additionally it provides valuable insights on clinical and research developments to share with the cutaneous lymphoma community.
Leaders from the CLTG joined other cutaneous lymphoma experts at the Foundation's 2009 Cutaneous Lymphoma Summit. The Summit, the first of its kind, brought together over 100 clinical and research experts for a two-day scientific program. Several of the experts were also presenters at the Cutaneous Lymphoma Patient Educational Forum being held at the same time.
The Foundation regularly attends the EORTC-CLTG's annual scientific meeting to help bring awareness of the patient perspective. It has also offered its Young Investigator Award to new physicians and scientists who are presenting research in the field of cutaneous lymphoma to attend the scientific meeting.